- Tehran University, Iran - MD
- Cleveland Clinic Foundation - Combined residency in Internal Medicine and Pediatrics
- National Institutes of Health - National Heart, Lung and Blood Institute - Fellowship in Hematology
- National Institutes of Health - National Heart, Lung and Blood Institute - Research fellowship
Dr. Peiman Hematti is a faculty member in the Division of Hematology, Medical Oncology and Palliative Care. He holds joint appointments in the Department of Pediatrics, Department of Surgery, and Department of Biomedical Engineering. Dr. Hematti participates in clinical care of bone marrow transplant patients. He directs the Clinical Hematopoietic Cell Processing Laboratory and serves as medical director of the Apheresis and Hematopoietic Cell Collection facility at UW Health. In those capacities, Dr. Hematti oversees all bone marrow and stem cell collections and clinical processing procedures for hematopoietic cell transplantation or other cellular therapy applications at UW Health. Dr. Hematti is board-certified in internal medicine, pediatrics, and hematology. He is a member of the American Society for Blood and Marrow Transplantation, the American Society of Gene Therapy, the American Society of Hematology, the International Society for Cellular Therapy, the International Society for Experimental Hematology, the International Society for Stem Cell Research, the American Association of Blood Banks, the American Society of Transplantation, the American Medical Association, the American Association of Immunologists, the Society for Immunotherapy of Cancer, and the Biomedical Engineering Society. Dr. Hematti serves as co-chair of the Autoimmune Diseases and Cellular Therapy Working Committee for the Center for International Blood and Marrow Transplant Research (CIBMTR). He has been inventor on several patents in the field of cellular therapy, and has received a WARF Innovation Award, a UW-Madison Distinguished Honors Faculty Award, and a National Blood Foundation Scholar Award, among other honors.
Dr. Hematti’s clinical interests include bone marrow transplant (BMT), CAR T-cell therapy (CAR-T), and inpatient care of hematopoietic stem cell transplant patients.
View Dr. Peiman Hematti’s Publications on NCBI PubMed
Dr. Hematti’s clinical and translational research program focuses on the prevention and treatment of graft versus host disease and other post-transplant immunological complications, use of novel cellular therapies for cancer treatment, and use of bone marrow stem cells in transplant and regenerative medicine. Dr. Hematti’s laboratory research focuses on immunobiology of stem cell transplantation with a special focus on investigating the anti-inflammatory and tissue regenerative properties of macrophages.